Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation, Childhood Cancer Survivors' Quality of Life, and Neutropenia and Cancer Infections.
Clinical Analysis of Tuberculosis in Children and Adolescents Treated for Malignancy or Undergoing Hematopoietic Cell Transplantation-A Multicenter Nationwide Study.
Changing scenario in prevention and management of CMV infections in pediatric hematopoietic stem cell transplant patients.
Survey on ICU organization and admission after hematopoietic cell transplantation - a report by IDWP and TCWP of the EBMT.
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT.
<span class="word">The <span class="word"><span class="changedDisabled">Outcomes <span class="word">of <span class="word"><span class="changedDisabled">Myeloid <span class="word"><span class="changedDisabled">Sarcoma <span class="word">in <span class="word">64 <span class="word"><span class="changedDisabled">Pediatric <span class="word"><span class="changedDisabled">Patients <span class="word">and <span class="word">the <span class="word"><span class="changedDisabled">Impact <span class="word">o
Hypertriglyceridemia During Anticancer Therapy in Pediatric Patients with Acute Lymphoblastic Leukemia - A Nationwide Experience.
Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registry.
The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results.
Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study.
Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival - an EBMT PDWP retrospective study.
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study.
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee.
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging.
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT.
Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10).
Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the Infectious Diseases Working Party of the EBMT
Next-Generation Sequencing for Infectious Disease Diagnostics in Pediatric Patients with Malignancies or After Hematopoietic Cell Transplantation: A Systematic Review.
Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee
A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMT
Iron Dysregulation Signature in Pediatric Leukemia: In-Depth Biomarkers of Iron Metabolism Involving Matriptase-2 and Neogenin-1.
Prognostic Role of Systemic Inflammatory Markers in Pediatric Soft-Tissue Sarcoma: A Multicenter Study of 213 Patients.
Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.
Posterior Reversible Encephalopathy Syndrome in Children with Malignancies or After Hematopoietic Cell Transplantation: A Polish Nationwide Study.
Clinical Analysis of <i>Acinetobacter</i> Species Infections in Children and Adolescents Treated for Cancer or Undergoing Hematopoietic Cell Transplantation: A Multicenter Nationwide Study.
<i>Erratum</i> to<i>: “</i>Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study”
Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival – an EBMT PDWP retrospective study
From Local to International Approach: Prognostic Factors and Treatment Outcomes in Neuroblastoma-A 30-Year Single-Center Retrospective Analysis.
Expression of TIM-3 and Gal-9 Immune Checkpoints in Chronic Lymphocytic Leukemia: The Potential Role of Interleukin-27.
Factor VII-Activating Protease (FSAP) and Its Importance in Hemostasis-Part II: A Link Between FSAP, Blood Coagulation, and Fibrinolysis: A Narrative Review.
Predictors in Optic Pathway Gliomas in Neurofibromatosis Type 1: A Single Center Study.